Related Experiment Video
Updated: Feb 20, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Antibody-Antibiotic Conjugates: Mechanisms, Clinical Progress, and Next-Generation Strategies Against
Parvin Askari1, Soudabeh Eshaghi1, Leila Omidvar2
1Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Antibody-antibiotic conjugates (AACs) offer targeted delivery of antibiotics to combat multidrug-resistant bacteria. This review details AAC development, mechanisms, and clinical potential against challenging infections.
Area of Science:
- Microbiology
- Immunology
- Pharmacology
Background:
- Multidrug-resistant (MDR) bacteria pose a significant global health threat.
- Conventional antibiotics face limitations against MDR pathogens.
- Antibody-antibiotic conjugates (AACs) offer a novel therapeutic strategy.
Purpose of the Study:
- To provide a comprehensive review of Antibody-Antibiotic Conjugate (AAC) development.
- To analyze the mechanisms of AAC-mediated bacterial clearance.
- To discuss the clinical development, challenges, and future directions of AACs.
Main Methods:
- Review of existing literature on AAC development, components, and mechanisms.
- Analysis of AAC evolution from early concepts to modern designs.
- Examination of clinical trial data, pharmacokinetics, and pharmacodynamics.
Main Results:
- AACs combine antibody specificity with antibiotic potency for targeted bacterial killing.
- Mechanisms include targeted payload release, Fc-mediated immunity, and intracellular delivery.
- AACs show promise for intracellular infections and biofilms.
Conclusions:
- AACs represent a transformative platform for precision antimicrobial therapy.
- They offer a promising approach to combatting MDR bacterial infections.
- Addressing challenges in antigen selection, immunogenicity, and manufacturing is key for next-generation AACs.
More Related Videos
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance
Antibiotic Selection
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Microorganisms in Medicine and Therapeutics